Description

AQUAPHARM CHEMICAL LIMITED has fixed Record Date of January 13, 2026 for payment of interest and part redemption of NCDs, reducing face value to Rs. 70,000 per debenture.

Summary

AQUAPHARM CHEMICAL LIMITED has announced part redemption of its Non-Convertible Debentures (NCDs) with a record date of January 13, 2026. The debentures will trade with reduced face value of Rs. 70,000 per debenture effective from the record date. This corporate action includes both payment of interest and partial redemption of the debentures.

Key Points

  • Company: AQUAPHARM CHEMICAL LIMITED
  • ISIN: INE0SYQ07015
  • Scrip Code: 975354
  • Debenture Series: ACL-8.90%-29-1-29-PVT
  • Record Date: January 13, 2026
  • Purpose: Part Redemption of Debentures and Payment of Interest
  • Reduced Face Value: Rs. 70,000 per Debenture
  • Effective Date: January 13, 2026
  • Settlement Number: DR-797/2025-2026

Regulatory Changes

No regulatory changes are introduced by this circular. This is a standard corporate action notification.

Compliance Requirements

  • Trading members must note that trading in the debentures will be conducted with the reduced face value effective from January 13, 2026
  • All trading systems and records should reflect the new face value post the effective date
  • Members should inform their clients holding these debentures about the part redemption and interest payment

Important Dates

  • Circular Date: January 9, 2026
  • Record Date: January 13, 2026
  • Effective Date for Reduced Face Value: January 13, 2026

Impact Assessment

This is a routine corporate action with limited market impact. The part redemption affects only holders of AQUAPHARM CHEMICAL LIMITED’s specific debenture series (ACL-8.90%-29-1-29-PVT). The reduction in face value to Rs. 70,000 per debenture will be reflected in trading from the effective date. Trading members need to update their systems accordingly to ensure proper valuation and settlement of these securities.

Impact Justification

Routine corporate action affecting specific debenture holders of a single company with no broader market implications